A dedicated EHRA Innovation Stage will showcase inventions for cardiac rhythm management from clinicians, scientists and engineers, culminating in a prize for the top three. Stay tuned for new software, devices, or other creations.

EHRA 2019 covers all aspects of arrhythmias, including devices and ablation of atrial fibrillation and ventricular tachycardia, as well as sudden cardiac death. Nearly 4,000 scientists and healthcare professionals from over 80 countries are expected to attend


Professor Haran Burri, Chairperson of the Scientific Programme, said: “Innovation is very much the theme of EHRA 2019. From world-class late-breaking trials to the abstract programme, cutting-edge technologies, and presentations by inventors, this is the place to hear what’s on the horizon in the diagnosis and treatment of cardiac arrhythmias.”


About the European Heart Rhythm Association
The European Heart Rhythm Association (EHRA) is a branch of the European Society of Cardiology (ESC). Its aim is improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances. EHRA ensures the dissemination of knowledge and standard setting; provides continuous education, training and certification to physicians and allied professionals involved in the field of cardiac arrhythmias with a special focus on Atrial Fibrillation (AF) and Electrophysiology (EP).


About the EHRA Congress
EHRA 2019 is the annual congress of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).


About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

Back to HCB News

Cardiology Homepage